Abstract
In the past, endothelium was thought to be only a mechanical barrier. Today, endothelium is known to be a tissue regulating vascular tone, cell growth and the interaction between the leukocytes, thrombocytes and the vessel wall. It also synthesizes growth factors and thrombo-regulatory molecules and responds to physical and chemical signals. Even though the term “endothelial dysfunction” is generally used for deterioration of endothelium-dependent vasodilatation; the term also includes the abnormalities between endothelium and leukocytes, thrombocytes and regulatory molecules and conditions resulting in aberrant endothelium activation. Healthy endothelium is essential for cardiovascular control. Thus, it plays an important role in pathogenesis of many diseases and cardiovascular problems such as atherosclerosis, systemic and pulmonary hypertension, cardiomyopathies and vasculitides. The aim of this chapter is to explain endothelial dysfunction and the circulating molecules of endothelial cells as they become potential targets of therapeutic approach for hypertension. This chapter reviews the roles of endothelial dysfunction in hypertension by addressing (1) the nature of endothelial function, (2) mechanisms of endothelial dysfunction and its relationship with the diseases (3) also endothelial function testing (4) the role of endothelial dysfunction and hypertension and (4) the effects of antihypertensive therapeutic options on the endothelial dysfunction. In addition to these, the role of endothelial dysfunction in white coat hypertension has been discussed. The key connections between hypertension and endothelial dysfunction are vitally important for future studies to permit new interventions to be designed and released.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ahmad A, Singhal U, Hossain MM, Islam N, Rizvi I (2013) The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension. J Clin Diagn Res 7:987–990
Anders HJ, Baumann M, Tripepi G, Mallamaci F (2015) Immunity in arterial hypertension: associations or causalities. Nephrol Dial Transplant 30:1959–1964
Armas-Padilla MC, Armas-Hernández MJ, Sosa-Canache B, Cammarata R, Pacheco B, Guerrero J, Carvajal AR, Hernández-Hernández R, Israili ZH, Valasco M (2007) Nitric oxide and malondialdehyde in human hypertension. Am J Ther 14:172–176
Arora P, Arora A, Sharma S (2013) Vascular endothelium dysfunction and hypertension: insight on molecular basics. Innov Pharm Pharmacother 1:199–219
Bae SW, Kim HS, Cha YN, Park YS, Jo SA, Jo I (2003) Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway. Biochem Biophys Res Commun 306:981–987
Ballermann BJ, Dardik A, Eng E, Liu A (1998) Shear stress and the endothelium. Kidney Int Suppl 67:S100–S108
Barnathan ES, Kuo A, Karikó K, Rosenfeld L, Murray SC, Behrendt N, Rønne E, Weiner D, Henkin J, Cines DB (1990) Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and mRNA. Blood 76:1795–1806
Barton M (2011) The discovery of endothelium-dependent contraction: the legacy of Paul M. Vanhoutte Pharmacol Res 63:455–462
Bauer J, Ripperger A, Frantz S, Ergün S, Schwedhelm E, Benndorf RA (2014) Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation. Br J Pharmacol 171:3115–3131
Bełtowski J (2012) Leptin and the regulation of endothelial function in physiological and pathological conditions. Clin Exp Pharmacol Physiol 39:168–178
Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, de Marchena E, Ahn YS (2003) High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145:962–970
Bjorklund K, Lind L, Vessby B, Andren B, Lithell H (2002) Different metobolic predictors of white-coat and sustained hypertension over a 20-year follow up. Circulation 106:63–68
Block G, Jensen CD, Norkus EP, Hudes M, Crawford PB (2008) Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young Black and White women. Nutr J 7:35.1–9
Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23:168–175
Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104:2649–2652
Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D (2016) White-coat hypertension and cardiovascular events: a meta-analysis. J Hypertens 34:593–599
Cahill PA, Redmond EM (2016) Vascular endothelium – gatekeeper of vessel health. Atherosclerosis 248:97–109
Calver A, Collier J, Vallance P (1993) Nitric oxide and cardiovascular control. Exp Physiol l78:303–326
Caner M, Karter Y, Uzun H, Curgunlu A, Vehid S, Balci H, Yucel R, Güner I, Kutlu A, Yaldiran A, Oztürk E (2006) Oxidative stress in human in sustained and white coat hypertension. Int J Clin Pract 60:1565–1571
Cardillo C, Felice FD, Campia U, Folli G (1993) Psychological reactivity and cardiac end organ changes in white coat hypertension. Hypertension 21:836–844
Celık T, Balta S, Karaman M, Ahmet Ay S, Demırkol S, Ozturk C, Dınc M, Unal HU, Yılmaz MI, Kılıc S, Kurt G, Tas A, Iyısoy A, Quartı-Trevano F, Fıcı F, Grassı G (2015) Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan. Blood Press 24:55–60
Cengiz M, Yavuzer S, Kılıçkıran Avcı B, Yürüyen M, Yavuzer H, Dikici SA, Karataş ÖF, Özen M, Uzun H, Öngen Z (2015) Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension. Clin Exp Hypertens 37:643–649
Ceriello A (2008) Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care Am Diabetes Assoc 31(Supl 2):S181–S184
Chappell MC (2016) Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Physiol Heart Circ Physiol 310:H137–H152
Chaumais MC, Guignabert C, Savale L, Jaïs X, Boucly A, Montani D, Simonneau G, Humbert M, Sitbon O (2015) Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension. Am J Cardiovasc Drug 15:13–26
Chistiakov DA, Orekhov AN, Bobryshev YV (2015) Endothelial barrier and its abnormalities in cardiovascular disease. Front Physiol 6:1–11
Coban E, Ozdoğan M, Ermiş C (2004) Plasma levels of homocysteine in patients with white-coat hypertension. Int J Clin Pract 58:997–999
Costa MA, Lopez Verrilli MA, Gomez KA, Nakagawa P, Peña C, Arranz C, Gironacci MM (2010) Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 299:H1205–H1211
Croft M, So T, Duan W, Soroosh P (2009) The significance of OX40 and OX40L to T cell biology and immune disease. Immunol Rev 229:173–191
Crowley SD (2014) The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal 20:102–120
Curgunlu A, Uzun H, Bavunoğlu I, Karter Y, Genç H, Vehid S (2005a) Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J Hum Hypertens 19:629–633
Curgunlu A, Karter Y, Uzun H, Aydin S, Ertürk N, Vehid S, Simsek G, Kutlu A, Oztürk E, Erdine S (2005b) Hyperhomocysteinemia: an additional risk factor in white coat hypertension. Int Heart J 46:245–254
Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G (2015a) Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis. Blood Press Monit 20:57–63
Cuspidi C, Rescaldani M, Tadic M, Sala C, Grassi G, Mancia G (2015b) White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis. J Hypertens 33:24–32
Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ (2016) Endothelin. Pharmacol Rev 68:357–418
Dawes MG, Bartlett G, Coats AJ, Juszczak E (2008) Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting. Ann Fam Med 6:390–396
Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH (1991) Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci 88:7797–7801
De Ciuceis C, Rossini C, La Boria E, Porteri E, Petroboni B, Gavazzi A, Sarkar A, Rosei EA, Rizzoni D (2014) Immune mechanisms in hypertension. High Blood Press Cardiovasc Prev 21:227–234
De Miguel C, Rudemiller NP, Abais JM, Mattson DL (2015) Inflammation and hypertension: new understandings and potential therapeutic targets. Curr Hypertens Rep 17:507
Dohi Y, Thiel MA, Buhler FR, Luscher TF (1990) Activation of the endothelial L-arginine pathway in pressurized mesenteric resistance arteries: effect of age and hypertension. Hypertension 15:170–179
Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S (2008) The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 409:349–355
Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992
Ercan M, Konukoglu D, Onen S (2003) Plasma viscosity as a cardiovascular risk marker in patients with proteinuria. Clin Hemorheol Microcirc 29:111–116
Ercan M, Firtina S, Konukoglu D (2014) Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia. Clin Hemorheol Microcirc 57:315–323
Esmon CT (2006) Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost 32(Suppl 1):49–60
Fagard RH, Cornelissen VA (2007) Incidence of cardiovascular events in white-coat, masked and sustained hypertension vs. true normotension: a meta-analysis. J Hypertens 25:2193–2198
Félétou M, Vanhoutte PM (2006) Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 26:1215–1225
Ferri C, Desideri G, Baldoncini R, Bellini C, De Angelis C, Mazzocchi C, Santucci A (1998) Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes 47:660–667
Ferroni P, Basili S, Paoletti V, Davì G, Psaty BM (2006) Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis 16:222–233
Francis SH, Busch JL, Corbin JD, Sibley D (2010) cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62:525–563
Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O’Brien E, Staessen JA, International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators (2012) Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension 59:564–571
Gimenez M, Schickling BM, Lopes LR, Miller FJ Jr (2016) Nox1 in cardiovascular diseases: regulation and pathophysiology. Clin Sci 130:151–165
Goldenberg NM, Kuebler WM (2015) Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation. Comp Physiol 5:531–559
Gomez-Cerezo J, Ríos Blanco JJ, Suárez García I, Moreno Anaya P, García Raya P, Vázquez-Muñoz E, Barbado Hernández FJ (2002) Noninvasive study of endothelial function in white coat hypertension. Hypertension 40:304–309
González J, Valls N, Brito R, Rodrigo R (2014) Essential hypertension and oxidative stress: new insights. World J Cardiol 6:353–366
Gunnett C, Lund D, McDowell A, Faraci F, Heistad D (2005) Mechanisms of inducible nitric oxide synthaseemediated vascular dysfunction. Arterioscler Thromb Vasc Biol 25:1617–1622
He Y, Si D, Yang C, Ni L, Li B, Ding M, Yang P (2014) The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension. Am J Hypertens 27:27–31
Helbing T, Olivier C, Bode C, Moser M, Diehl P (2014) Role of microparticles in endothelial dysfunction and arterial hypertension. World J Cardiol 6:1135–1139
Hirata Y, Nagata D, Suzuki E, Nishimatsu H, Suzuki J, Nagai R (2010) Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int Heart J 51:1–6
Hlubocka Z, Umnevora V, Heller S et al (2002) Circulating intercellular cell adhesion molecule-1, endothelin-1and von willebrand factor-markers of endothelial dysfunction in uncomplicated essensial hypertension: the effect of treatment with ACE inhibitors. J Hum Hypertens 16:557–562
Hoegholm A, Bang LE, Kristensen KS, Nielsen JW, Holm J (1994) Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension and normotension. Hypertension 24:101–105
Hsueh WA, Quiñones MJ (2003) Role of endothelial dysfunction in insulin resistance. Am J Cardiol 92:10J–17J
Idris-Khodja N, Mian MO, Paradis P, Schiffrin EL (2014) Dual opposing roles of adaptive immunity in hypertension. Eur Heart J 35:1238–1244
Jacobsen JC, Hornbech MS, Holstein-Rathlou NH (2011) Significance of microvascular remodelling for the vascular flow reserve in hypertension. Interface Focus 1:117–131
Jaipersad AS, Lip GY, Silverman S, Shantsila E (2014) The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol 63:1–11
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:507–520
Jarajapu YP, Bhatwadekar AD, Caballero S, Hazra S, Shenoy V, Medina R, Kent D, Stitt AW, Thut C, Finney EM, Raizada MK, Grant MB (2013) Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors. Diabetes 62:1258–1269
Jiang F, Yang J, Zhang Y, Dong M, Wang S, Zhang Q, Liu FF, Zhang K, Zhang C (2014) Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Nat Rev Cardiol 11:413–426
Julius S, Mejia A, Jones K et al (1990) ‘White coat’ versus ‘sustained’ borderline hypertension in Tecimseh, Michigan. Hypertension 16:617–623
Karter Y, Ertürk NT, Aydín S, Curgunlu A, Uzun H, Vehid S, Kutlu AO, Yaldiran A, Oztürk E, Erdine S, Sipahioğlu F (2003) Endothelial dysfunction in sustained and white coat hypertension. Am J Hypertens 16:892
Karter Y, Aydin S, Curgunlu A, Uzun H, Ertürk N, Vehid S, Kutlu A, Simsek G, Yücel R, Arat A, Ozturk E, Erdine S (2004) Endothelium and angiogenesis in white coat hypertension. J Hum Hypertens 18:809–814
Kedzierski RM, Yanagisawa M (2001) Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41:851–876
Kellogg D, Zhao J, Coey U, Green J (2005) Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol 98:629–632
Kelly AS, Gonzalez-Campoy JM, Rudser KD, Katz H, Metzig AM, Thalin M, Bank AJ (2012) Carvedilol-lisinopril combination therapy and endothelial function in obese individuals with hypertension. J Clin Hypertens 14:85–91
Khazaei M, Moien-afshari F, Laher I (2008) Vascular endothelial function in health and diseases. Pathophysiology 15:49–67
Kim YW, Byzova TV (2014) Oxidative stress in angiogenesis and vascular disease. Blood 123:625–631
Kiowski W (1999) Endothelial dysfunction in hypertension. Clin Exp Hypertens 21:635–646
Kleinegris MC, Ten Cate-Hoek AJ, Ten Cate H (2012) Coagulation and the vessel wall in thrombosis and atherosclerosis. Pol Arch Med Wewn 122:557–566
Kobayashi T, Nogami T, Taguchi K, Matsumoto T, Kamata K (2008) Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK. Br J Pharmacol 155:974–983
Kolluru GK, Sinha S, Majumder S, Muley A, Siamwala JH, Gupta R, Chatterjee S (2010) Shear stress promotes nitric oxide production in endothelial cells by sub-cellular delocalization of eNOS: a basis for shear stress mediated angiogenesis. Nitric Oxide 22:304–315
Konukoglu D, Serin O, Ercan M, Turhan M (2003) Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper. Clin Biochem 36:405–408
Konukoglu D, Serin O, Turhan MS (2006) Plasma leptin and its relationship with lipid peroxidation and nitric oxide in obese female patients with or without hypertension. Arch Med Res 37:602–606
Konukoglu D, Firtina S, Serin O, Cavusoglu C (2009) Relationship among plasma secretory phospholipase A2, oxidized low density lipoprotein & paraoxonase activities in hypertensive subjects treated with angiotensin converting enzyme inhibitors. Indian J Med Res 129:390–394
Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2014) Cyclooxygenase pathways. Acta Biochim Pol 61:639–649
Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V (1998) The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med 338:784–790
Lacave R, Rondeau E, Ochi S, Delarue F, Schleuning WD, Sraer JD (1989) Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int 35:806–811
Laher I (ed) (2014) Systems biology of free radicals and antioxidants book. Springer, Berlin/Heidelberg
Lee R, Margaritis M, Channon KM, Antoniades C (2012) Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem 19:2504–2520
Lengyel S, Katona E, Zatik J, Molnár C, Paragh G, Fülesdi B, Páll D (2012) The impact of serum homocysteine on intima-media thickness in normotensive, white-coat and sustained hypertensive adolescents. Blood Press 21:39–44
Lerman A, Burnett JC Jr (1992) Intact and altered endothelium in regulation of vasomotion. Circulation 86(suppl III):III-12–II-19
Levesque MJ, Nerem RM, Sprague EA (1990) Vascular endothelial cell proliferation in culture and the influence of flow. Biomaterials 11:702–707
Li Y, Haga C, Chien S (2005) Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech 38:1949–1971
Li S, Wu Y, Yu G, Xia Q, Xu Y (2014) Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials. PLoS One 9, e90217
Lijnen HR, Collen D (1997) Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis 39:343–350
Lin YJ, Juan CC, Kwok CF, Hsu YP, Shih KC, Chen CC, Ho LT (2015) Endothelin-1 exacerbates development of hypertension and atherosclerosis in modest insulin resistant syndrome. Biochem Biophys Res Commun 460:497–503
Loukogeorgakis SP, van den Berg MJ, Sofat R, Nitsch D, Charakida M, Haiyee B, de Groot E, MacAllister RJ, Kuijpers TW, Deanfield JE (2010) Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans. Circulation 121:2310–2316
Lowenstein CJ, Padalko E (2004) iNOS (NOS2) at a glance. J Cell Sci 117:2865–2867
Luksha L, Agewall S, Kublickiene K (2009) Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis 202:330–344
Luscher TF (1991) Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system. Eur Heart J 12(Suppl E):2–11
Luscher TF, Vanhoutte PM (1986) Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8:344–348
Lüscher TF, Yang ZH, Diederich D, Bühler FR (1989) Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion. J Cardiovasc Pharmacol 14(Suppl 6):S63–S69
Mai J, Virtue A, Shen J, Wang H, Yang X-F (2013) An evolving new paradigm: endothelial cells–conditional innate immune cells. J Hematol Oncol 6:61
Mancia G, Fagard R, Narkiewicz K et al (2013) ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219
Marchi-Alves LM, Carnio EC (2009) Is there any correlation between insulin resistance and nitrate plasma concentration in white coat hypertensive patients? Cardiol Res Pract 2009:376735
Marques FK, Campos FM, Sousa LP, Teixeira-Carvalho A, Dusse LM, Gomes KB (2013) Association of microparticles and preeclampsia. Mol Biol Rep 40:4553–4559
Masuyer G, Yates CJ, Sturrock ED, Acharya KR (2014) Angiotensin-I converting enzyme (ACE): structure, biological roles, and molecular basis for chloride ion dependence. Biol Chem 395:1135–1149
Matavelli LC, Siragy HM (2015) AT2 receptor activities and pathophysiological implications. J Cardiovasc Pharmacol 65:226–232
McCully KS (2015) Homocysteine and the pathogenesis of atherosclerosis. Expert Rev Clin Pharmacol 8:211–219
McIntyre M, Bohr DF, Dominiczak AF (1999) Endothelial function in hypertension: the role of superoxide anion. Hypertension 34:539–545
Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454:428–435
Melikian N, Seddon MD, Casadei B, Chowienczyk PJ, Shah AM (2009) Neuronal nitric oxide synthase and human vascular regulation. Trends Cardiovasc Med 19:256–262
Mendoza-Torres E, Oyarzún A, Mondaca-Ruff D, Azocar A, Castro PF, Jalil JE, Chiong M, Lavandero S, Ocaranza MP (2015) ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension. Ther Adv Cardiovasc Dis 9:217–237
Michalsen A, Li C (2013) Fasting therapy for treating and preventing disease – current state of evidence. Forsch Komplementmed 20:444–453
Michel T, Vanhoutte PM (2010) Cellular signaling and NO production. Pflugers Arch - Eur J Physiol 459:807–816
Montezano AC, Tsiropoulou S, Dulak-Lis M, Harvey A, Camargo Lde L, Touyz RM (2015a) Redox signaling, Nox5 and vascular remodeling in hypertension. Curr Opin Nephrol Hypertens 24:425–433
Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM (2015b) Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol 31:631–641
Mullen MJ, Clarkson P, Donald AE, Thomson H, Thorne SA, Powe AJ, Furuno T, Bull T, Deanfield JE (1998) Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. J Am Coll Cardiol 31:1330–1335
Muniyappa R, Sowers JR (2013) Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord 14:5–12
Napoli C, Salomone S, Godfraind T, Palinski W, Capuzzi DM, Palumbo G, D’Armiento FP, Donzelli R, de Nigris F, Capizzi RL, Mancini M, Gonnella JS, Bianchi A (1999) 1,4-Dihydropyridin ealcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. Stroke 30:1907–1915
Oparil S, Zaman MA, Calhoun DA (2003) Pathogenesis of hypertension. Ann Intern Med 139:761–776
Ouweneel AB, Van Eck M (2016) Lipoproteins as modulators of atherothrombosis: from endothelial function to primary and secondary coagulation. Vascul Pharmacol 82:1–10
Palmer RM, Ashton D, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664–666
Papageorgiou N, Androulakis E, Papaioannou S, Antoniades C, Tousoulis D (2015) Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease. Amino Acids 47:1741–1750
Pastrana JL, Sha X, Virtue A, Mai J, Cueto R, Lee IA, Wang H, Yang XF (2012) Regulatory T cells and Atherosclerosis. J Clin Exp Cardiol 2012(Suppl 12):002–019
Perutelli P, Marchese P, Mori PG (1992) The glycoprotein IIb/IIIa complex of the platelets. An activation-dependent integrin. Recenti Prog Med 83:100–104
Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH (1988) How common is white coat hypertension. JAMA 259:225–228
Pierdomenico SD, Cuccurullo F (2011) Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta-analysis. Am J Hypertens 24:52–58
Pierdomenico SD, Bucci A, Lapenna D, Lattanzio FM, Talone L, Cuccurullo F, Mezzetti A (2003) Circulating homocysteine levels in sustained and white coat hypertension. J Hum Hypertens 17:165–170
Pirillo A, Norata GD, Catapano AL (2013) LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm 2013:1–13
Prasad A, Tupas-Habib T, Schenke WH, Mincemoyer R, Panza JA, Waclawiw MA, Ellahham S, Quyyumi AA (2000) Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation 101:2349–2354
Prasad A, Halcox JPJ, Waclawiw MA, Quyyumi AA (2001) Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis. J Am Coll Cardiol 38:1089–1095
Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS (2003) Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41:211–217
Prieto D, Contreras C, Sánchez A (2014) Endothelial dysfunction, obesity and insulin resistance. Curr Vasc Pharmacol 12:412–426
Pushpakumar S, Kundu S, Sen U (2014) Endothelial dysfunction: the link between homocysteine and hydrogen sulfide. Curr Med Chem 21:3662–3672
Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, Nishigaki I (2013) The vascular endothelium and human diseases. Int J Biol Sci 9:1057–1069
Ralevic V, Dunn WR (2015) Purinergic transmission in blood vessels. Auton Neurosci 191:48–66
Rao A, Pandya V, Whaley-Connell A (2015) Obesity and insulin resistance in resistant hypertension: implications for the kidney. Adv Chronic Kidney Dis 22:211–217
Reneman RS, Arts T, Hoeks AP (2006) Wall shear stress–an important determinant of endothelial cell function and structure in the arterial system in vivo. Discrepancies with theory. J Vasc Res 43:251–269
Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bächler JP (2007) Relationship between oxidative stress and essential hypertension. Hypertens Res 30:1159–1167
Rodrigo R, Libuy M, Feliú F, Hasson D (2013) Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers 35:773–790
Rodriguez-Iturbe B, Pons H, Quiroz Y, Lanaspa M, Johnson RJ (2014) Autoimmunity in the pathogenesis of hypertension. Nat Rev Nephrol 10:56–62
Salame MY, Samani NJ, Masood I, deBono DP (2000) Expression of the plasminogen activator system in the human vascular wall. Atherosclerosis 152:19–28
Salomone S, Drago F (2012) Effects of PPARγ ligands on vascular tone. Curr Mol Pharmacol 5:282–291
Santilli F, D’Ardes D, Davì G (2015) Oxidative stress in chronic vascular disease: from prediction to prevention. Vasc Pharmacol 74:23–37
Shih GC, Hajjar KA (1993) Plasminogen and plasminogen activator assembly on the human endothelial cell. Proc Soc Exp Biol Med 202:258–264
Siervo M, Corander M, Stranges S, Bluck L (2011) Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA). Nutr Metab Cardiovasc Dis 21:1–10
Sindone A, Erlich J, Lee C, Newman H, Suranyi M, Roger SD (2016) Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to? Intern Med J 46:364–372
Siti HN, Kamisah Y, Kamsiah J (2015) The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease. Vasc Pharmacol 71:40–56
Soma J, Aakhus S, Dahl K, Slørdahl S, Wiseth R, Widerøe TE, Skjaerpe T (1996) Hemodynamics in white coat hypertension compared to ambulatory hypertension and normotension. Am J Hypertens 9:1090–1098
Spence S, Anderson C, Cukierski M, Patrick D (1999) Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat. Reprod Toxicol 13:15–29
Stancel N, Chen CC, Ke LY, Chu CS, Lu J, Sawamura T, Chen CH (2016) Interplay between crp, atherogenic ldl, and lox-1 and its potential role in the pathogenesis of atherosclerosis. Clin Chem 62:320–327
Steffel J, Lüscher TF, Tanner FC (2006) Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113:722–731
Stenina OI (2003) Regulation of gene expression in vascular cells by coagulation proteins. Curr Drug Targets 4:143–158
Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, Boggia J, Johansson JK, Ohkubo T, Tsuji I, Jula AM, Imai Y, Staessen JA, International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators (2014) Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension 63:675–682
Strandherg TE, Salomaa V (2000) White coat effect, blood pressure and mortality in men: prospective cohort study. Eur Heart J 21:1714–1718
Su JB (2015) Vascular endothelial dysfunction and pharmacological treatment. World J Cardiol 7:719–741
Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S (2003) New markers of inflammation and endothelial cell activation: part I. Circulation 108:1917–1923
Tabak O, Gelisgen R, Uzun H, Kalender B, Balci H, Curgunlu A, Simsek G, Karter Y (2009) Hypertension and hemostatic/fibrinolytic balance disorders. Clin Invest Med 32:E285–E290
Thaete LG, Neerhof MG, Silver RK (2001) Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats. J Soc Gynecol Investig 8:18–23
Trask AJ, Ferrario CM (2007) Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments. Cardiovasc Drug Rev 25:162–174
Tschudi MR, Criscione L, Luscher TF (1991) Effect of aging and hypertension on endothelial function of rat coronary arteries. J Hypertens 9:164–165
Tselios K, Sarantopoulos A, Gkougkourelas I, Boura P (2014) T regulatory cells: a promising new target in atherosclerosis. Crit Rev Immunol 34:389–397
Tummala PE, Chen XL, Sundell CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM (1999) Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: potential link between the renin-angiotensin system and atherosclerosis. Circulation 100:1223–1229
Tuttolomondo A, Di Raimondo D, Pecoraro R, Arnao V, Pinto A, Licata G (2012) Atherosclerosis as an inflammatory disease. Curr Pharm Des 18:4266–4288
Tzemos N, Lim PO, MacDonald TM (2001) Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation 104:511–514
Uzun H, Karter Y, Aydin S, Curgunlu A, Simşek G, Yücel R, Vehiyd S, Ertürk N, Kutlu A, Benian A, Yaldiran A, Oztürk E, Erdine S (2004) Oxidative stress in white coat hypertension; role of paraoxonase. J Hum Hypertens 18:523–528
Vaindirlis I, Peppa-Patrikiou M, Dracopoulou M, Manoli I, Voutetakis A, Dacou-Voutetakis C (2000) ‘White coat hypertension’ in adolescents: increased values of urinary cortisol and endothelin. J Pediatr 136:359–364
Vaněčková I, Maletínská L, Behuliak M, Nagelová V, Zicha J, Kuneš J (2014) Obesity-related hypertension: possible pathophysiological mechanisms. J Endocrinol 223:R63–R78
Vanhoutte PM, Shimokawa H, Tang EH, Feletou M (2009) Endothelial dysfunction and vascular disease. Acta Physiol 196:193–222
Verdecchia P, Schillaci G, Boldrini P, Ciucci A, Porcellati C (1996) White coat hypertension. Lancet 348:1444–1445
Vestweber D (2012) Relevance of endothelial junctions in leukocyte xtravasation and vascular permeability. Ann N Y Acad Sci 1257:184–192
Virdis A, Duranti E, Taddei S (2011) Oxidative stress and vascular damage in hypertension: role of angiotensin II. Int J Hypertens 2011, 916310
Vyssoulis GP, Marinakis AG, Aznaouridis KA, Karpanou EA, Arapogianni AN, Cokkinos DV, Stefanadis CI (2004) The impact of thirdgeneration beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking. Am J Hypertens 17:582–589
Wang Y, Zhao S (2010) Vasoactivators and placental vasoactivity. Morgan & Claypool Life Sciences, San Rafael
Weber MA, Neutel JM, Smith DH, Graettinger WF (1994) Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 90:2291–2298
Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend R, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB (2014) Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 32:3–15
Weitzberg E, Hezel M, Lundberg JO (2010) Nitrate-nitrite-nitric oxide pathway: implications for anesthesiology and intensive care. Anesthesiology 113:1460–1475
Wenzel U, Turner JE, Krebs C, Kurts C, Harrison DG, Ehmke H (2016) Immune mechanisms in arterial hypertension. J Am Soc Nephrol 27:677–686
White WB, Schulman P, McCabe EJ, Dey HM (1989) Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 261:873–877
Wilson SH, Lerman A (2001) Function of vascular endothelium. In: Heart physiology and pathophysiology, vol 27. Elsevier Inc., New York
Winn RK, Harlan JM (2005) The role of endothelial cell apoptosis in inflammatory and immune diseases. J Thromb Haemost 3:1815–1824
Yasu T, Kobayashi M, Mutoh A, Yamakawa K, Momomura S, Ueda S (2013) Dihydropyridine calcium channel blockers inhibit non-esterified-fatty-acid-induced endothelial and rheological dysfunction. Clin Sci 125:247–255
Yasunari K, Maeda K, Nakamura M, Yoshikawa J (2002) Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 39:777–780
Yau JW, Teoh H, Verma S (2015) Endothelial cell control of thrombosis. BMC Cardiovasc Disord 15:130
Yavuzer S, Yavuzer H, Cengiz M, Erman H, Altıparmak MR, Korkmazer B, Balci H, Simsek G, Yaldıran AL, Karter Y, Uzun H (2015) Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1. J Hum Hypertens 29:92–98
Yavuzer H, Yavuzer S, Cengiz M, Erman H, Doventas A, Balci H, Erdincler DS, Uzun H (2016a) Biomarkers of lipid peroxidation related to hypertension in aging. Hypertens Res 39:342–348
Yavuzer H, Cengiz M, Yavuzer S, Rıza Altıparmak M, Korkmazer B, Balci H, Yaldıran AL, Uzun H (2016b) Procalcitonin and Pentraxin-3: current biomarkers in inflammation in white coat hypertension. J Hum Hypertens 30:424–429
Yayama K, Hiyoshi H, Imazu D, Okamoto H (2006) Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor. Hypertension 48:958–964
Youn JC, Yu HT, Lim BJ, Koh MJ, Lee J, Chang DY, Choi YS, Lee SH, Kang SM, Jang Y, Yoo OJ, Shin EC, Park S (2013) Immunosenescent CD8+ T clls and C-X-C cemokine receptor type 3 chemokines are increased in human hypertension. Hypertension 62:126–133
Yuana Y, Sturk A, Nieuwland R (2013) Extracellular vesicles in physiological and pathological conditions. Blood Rev 27:31–39
Zepeda RJ, Castillo R, Rodrigo R, Prieto JC, Aramburu I, Brugere S, Galdames K, Noriega V, Miranda HF (2012) Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension. Basic Clin Pharmacol Toxicol 111:309–316
Zhao Y, Vanhoutte PM, Leung SWS (2014) Vascular nitric oxide: beyond eNOS. J Pharmacol Sci 129:83–94
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this chapter
Cite this chapter
Konukoglu, D., Uzun, H. (2016). Endothelial Dysfunction and Hypertension. In: Islam, M.S. (eds) Hypertension: from basic research to clinical practice. Advances in Experimental Medicine and Biology(), vol 956. Springer, Cham. https://doi.org/10.1007/5584_2016_90
Download citation
DOI: https://doi.org/10.1007/5584_2016_90
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44250-1
Online ISBN: 978-3-319-44251-8
eBook Packages: MedicineMedicine (R0)